BioSpace News Archive

Business

Spark Therapeutics to Host Conference Call on Tuesday, Feb. 20 at 8:30 a.m. ET to Discuss 2017 Results and Recent Business Highlights

The call can be accessed by dialing (855) 851-4526 (domestic) or (720) 634-2901 (international), and entering passcode 9596288.

February 13, 2018

·

1 min read

BioCapital

OpGen Strengthens Supplier Relationship to Use Industry-Leading Real-Time PCR Technology for New Acuitas Tests

Test rapidly detects 47 antimicrobial resistance markers directly from urine and bacterial isolates.

February 13, 2018

·

4 min read

Business

Ziopharm Oncology to Announce Fourth Quarter and Full Year 2017 Year-end Financial Results and Host Conference Call on March 1

The call can be accessed by dialing 1-844-309-0618 (U.S. and Canada) or 1-661-378-9465 (international).

February 13, 2018

·

4 min read

Drug Development

Shire Provides Regulatory Progress Update for Key Pipeline Programs Targeting Rare Disease

Shire is preparing to conduct Phase 3 trials investigating SHP647 for the treatment of moderately to severely active Crohn’s disease in adults

February 13, 2018

·

10 min read

Business

RedHill Biopharma to Host Fourth Quarter and Full-Year 2017 Financial Results Conference Call on February 22, 2018

To participate in the conference call, please dial one of the following numbers 15 minutes prior to the start of the call:

February 13, 2018

·

5 min read

Conversion of FIT Biotech Oy’s Convertible Capital Notes Into Shares - Feb. 13, 2018

The Board authorization is based on the Extraordinary General Meeting December 14, 2017.

February 13, 2018

·

1 min read

Drug Development

Phase I/II Clinical Trial Results Positive for SpinalCyte’s CybroCell Dermal Fibroblasts

SpinalCyte’s Phase 1/2 trial is the first allogeneic use of fibroblasts outside of skin conditions.

February 13, 2018

·

4 min read

Median Technologies Announces Results of Deep Learning Study for Enhanced Prostate Segmentation - Helping to Advance Precision Medicine

Study results will be presented at the SPIE Medical Imaging conference in Houston, TX, USA on February 14.

February 13, 2018

·

3 min read

Business

Pilot Chemical Names Glynn Goertzen VP of Corporate Development

Pilot Chemical Company announced that Glynn Goertzen, president of Pilot Chemical subsidiary Liquid Minerals Group Ltd., also has been named vice president of corporate development for the parent company.

February 13, 2018

·

3 min read

Business

MOLOGEN Signs License Deal for China and Global Co-Development Agreement with ONCOLOGIE for Lead Compound lefitolimod

MOLOGEN announced today the signing of a license deal for the Chinese territory and a global co-development agreement between MOLOGEN and ONCOLOGIE Inc. for its lead compound lefitolimod.

February 13, 2018

·

6 min read